By Chris Driver, IQVIA
The use of "big data" in clinical trials has been a topic of discussion for over a decade. Trial sponsors face the challenge of handling vast and diverse data from multiple trial sites. With the right technology, sponsors can integrate extensive statistical information into adaptive trials, enabling real-time interim analysis.
Advancements in data-driven technology have empowered sponsors to make informed decisions about trial funding, treatment arm modifications, and other essential changes during the study. Despite the increasing manageability of vast data, extracting meaningful insights remains complex. However, clinical technology providers, particularly those offering interactive response technology (IRT), are leading the way in helping sponsors overcome these challenges.
By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.